Literature DB >> 5443383

Clinical associations of 11-hydroxycorticosteroid suppression and non-suppression in severe depressive illnesses.

B J Carroll, B Davies.   

Abstract

Fifty patients with severe depression were separated into two groups by the responses of their plasma 11-hydroxycorticosteriod levels to a midnight dose of 2 mg. of dexamethasone. Clinical and questionary comparisons were made between the two groups of patients, who were similar as regards age, sex, and length of symptoms before admission to hospital. No differences were found between the groups of severely ill patients as regards the severity of their depression and anxiety assessed by questionary. Nevertheless, agitation was significantly greater in the patients whose corticosteroid levels were not suppressed by dexamethasone and adverse childhood experiences in those whose levels were suppressed.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5443383      PMCID: PMC1699666          DOI: 10.1136/bmj.1.5699.789

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Pituitary-adrenal function in severe depressive illness.

Authors:  P W Butler; G M Besser
Journal:  Lancet       Date:  1968-06-08       Impact factor: 79.321

2.  Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients.

Authors:  W E Bunney; J A Fawcett; J M Davis; S Gifford
Journal:  Arch Gen Psychiatry       Date:  1969-08

3.  Hypothalamic--pituitary function in depressive illness: insensitivity to hylycaemia.

Authors:  B J Carroll
Journal:  Br Med J       Date:  1969-07-05

4.  Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness.

Authors:  B J Carroll; F I Martin; B Davies
Journal:  Br Med J       Date:  1968-08-03
  4 in total
  1 in total

Review 1.  Transsphenoidal surgery for Cushing's syndrome.

Authors:  J Nabarro
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.